ENTITY

Aerovate Therapeutics (AVTE US)

3
Analysis
Health Care • United States
Aerovate Therapeutics Inc. operates as a biotechnology company. The Company focuses on developing drugs that improve the lives of patients with cardiopulmonary disease. Aerovate Therapeutics serves medical industry in the United States.
more
Exchange Announcement • 30 Apr 2025 04:05

Current Report (Form 8-K | Period ending 2025-04-29)

Exchange Announcement • 26 Apr 2025 04:30

Quarterly Report (Form 10-Q | Period ending 2025-03-31)

Exchange Announcement • 24 Apr 2025 04:37

Current Report (Form 8-K | Period ending 2025-04-23)

Exchange Announcement • 21 Apr 2025 20:07

Current Report (Form 8-K | Period ending 2025-04-16)

Exchange Announcement • 10 Apr 2025 04:20

425 | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

x